RapidAI offers a software platform powered by AI for detecting and treating life-threatening vascular and neurovascular conditions, with a focus on aneurysms, pulmonary embolisms, and strokes. The platform enables faster decision-making for physicians based on intelligence gained from over 10 million scans in more than 2,000 hospitals.